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http://dx
1398Objective: This study assesses the performance and cellular features of decellularized ovine aortic homografts
coated with stromal cell–derived factor-1a (SDF-1a) and its natural linker, fibronectin (FN), after implantation
in the right ventricular outflow tract of adolescent sheep.
Methods: Right ventricular outflow tract reconstructions using cryopreserved (n ¼ 7), decellularized (n ¼ 8),
and decellularized FN/SDF-1a–coated aortic ovine homografts (n ¼ 6) were performed. Echocardiographic,
morphologic, radiographic, histologic, and immunohistochemical examinations were performed 5 months after
implantation.
Results: There were no hemodynamic differences between groups, except for the decellularized homografts’
tendency to develop more valve regurgitation (3 of 8 grafts had regurgitation>2/4). All decellularized, but
coated, grafts had normal hemodynamics. Decellularized valve conduits were less calcified than cryopreserved
conduits (P<.05), but coated valve conduits were free of calcification (P<.05). The samewas found for pannus
in the outflow parts. Immune response (CD45þ, CD45Rþ, or CD11bþ cells) was decreased in decellularized
valves compared with cryopreserved grafts, but was virtually absent (P< .05) in coated grafts. Collagen
organization and density in the leaflets and walls were decreased in cryopreserved and decellularized valves,
but not in coated valves (P<.05). Coating improved re-endothelialization (P<.05).
Conclusions: Coating of decellularized allografts with FN/SDF-1a prevents cryopreserved heart valve–
mediated immune response, conduit calcification, and pannus formation and stimulates re-endothelialization.
(J Thorac Cardiovasc Surg 2014;147:1398-404)Supplemental material is available online.
Clinical problems with cryopreserved homografts after the
Ross procedure are not related to the valve leaflets, but
rather to supravalvular conduit structures (ie, root calcifica-
tion and intimal hyperplasia of the conduit).1 Because root
calcification is related to calcium deposition on cell
remnants in the graft, several investigators hypothesized
that acellularization of the graft could prevent these calci-
fications.2 However, immune response is not completely
eliminated by decellularization alone, and inflammatorye Department of Cardiovascular Diseases,a University of Leuven, Leuven,
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The Journal of Thoracic and Cardiovascular Surcell infiltration and intimal hyperplasia in the conduits,
pannus formation, conduit degeneration, and calcification
remain a hazard. Therefore, additional coating with fibro-
nectin (FN)/stromal cell–derived factor 1 a (SDF-1a) might
be effective.
It is speculated,3 but not confirmed,2,4 that in
decellularized homografts spontaneous recellularization
will occur after implantation, revitalizing the graft with
autologous cells. However, spontaneous recellularization
of acellular homografts will be no more than a foreign
body reaction induced by innate or natural immunity.
CD11bþ macrophages accumulate at the interface between
the native tissue and the graft and participate in the
formation of granulation tissue and fibroblasts. Finally, a
fibrotic capsula or ‘‘pannus,’’ detrimental for the function
of the implant, surrounds the biomaterial implant. Also,
stem cells, which participate in inflammation and are
recruited to the injury sites, play a role in wound healing
and tissue regeneration because of their unique
regenerative properties. Recent studies have shown that
the implantation of biomaterials may prompt the
recruitment and local engraftment of autologous stem
cells, having the potential to recellularize the matrices.5,6
However, the inflammation-related intimal hyperplasiagery c April 2014
Abbreviations and Acronyms
ASMA ¼ alpha smooth muscle actin
FN ¼ fibronectin
IC ¼ interstitial cell
RVOT ¼ right ventricular outflow tract
SDF ¼ stromal cell–derived factor
SMMS ¼ smooth muscle myosin heavy chain
Flameng et al Evolving Technology/Basic Sciencedue tomacrophage differentiation ismuchmore pronounced
than the true tissue regeneration related to stem cell
attraction and adequate differentiation.6 Therefore, we
were specifically interested in SDF-1a because this factor
was shown, in addition to enhancement of local recruitment
of autologous stem cells, to modify and bypass the
detrimental inflammatory cell responses at the implant
interface.6-8
In this context, we studied the outcome of implanted
cryopreserved, acellularized, and FN/SDF-1a–enriched
acellular aortic homografts in a sheep model. We have
chosen the aortic, instead of the pulmonary, homograft
because it is shown clinically9 and experimentally10 that
the aortic homograft has themost fromoutflow tract obstruc-
tion and, thereby, became the second choice. Improvement
of the durability of the aortic homograft would expand the
available pool of suitable homografts significantly.METHODS
All animals were cared for in accordance with the Guide for the Care
and Use of Laboratory Animals (8th edition, 2011). Eleven Lovenaar sheep
were used for harvesting/cryopreservation of ovine aortic homografts.
Furthermore, 14 aortic ovine valve conduits were purchased from the local
slaughterhouse and processed for decellularization and eventual coating, as
described later. Twenty-one other Lovenaar sheep were used as valve
recipients undergoing right ventricular outflow tract (RVOT) reconstruc-
tion, according to the protocol described later.
The study was approved by the ethics committee for animal experiments
of the University of Leuven, Leuven, Belgium.E
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Hearts were harvested from male Lovenaar sheep (n ¼ 11; age, 371
[260-494] days; weight, 59 [50-82] kg) under sterile conditions, after full
heparinization, and immediately transferred to European Homograft
Bank11 in 4C sterile saline. Aortic valve conduits were dissected and
prepared for cryopreservation in a vertical laminar flow (class A) clean
room. Further details about the cryopreservation procedure were already
described.11 Four cryopreserved aortic conduits remained unimplanted
and were fixed in 4% paraformaldehyde for histology. The other 7 were
implanted as described later.
Decellularization and Impregnation
Fourteen aortic ovine valve conduits, obtained from the local slaughter-
house, were decellularized by detergents (sodium dodecyl sulfate and Triton
X-100), according to theprotocol alreadydescribedbyUeda andcoworkers.12
Six of these were impregnated with human FN (32 mg/cm2; Biomedical
Technologies, Stoughton,Mass) and SDF-1a (3.2 mg/cm2;Miltenyi Biotec,The Journal of Thoracic and CarBergisch Gladbach, Germany) (each for 24 hours at 4C), as already
described.7,8
Valve Implantation
Twenty-one female Lovenaar sheep were selected (age, 246 [151-418]
days; weight, 43 [30-57] kg) and randomly allocated to 3 groups, of
which each animal received an implant in pulmonary position, as listed:
(1) cryopreserved homografts (n ¼ 7), (2) decellularized homografts
(n ¼ 8), and (3) coated decellularized homografts (n ¼ 6).
The implantation technique was described before.10 In short, a left
thoracotomy was performed. After heparinization, cardiopulmonary
bypass was installed after cannulation of the left carotid artery and
jugular vein. Under conditions of normothermia and beating heart, the
pulmonary artery was crossclamped proximal from its bifurcation and
transected just distal from the commissures. The native pulmonary valve
leaflets were resected, and the homograft was implanted as a root
replacement.Echocardiography
On all animals undergoing RVOT reconstruction, transthoracic echocar-
diography was performed at 1 week and 5 months by an experienced
echocardiographer using a Vivid Five echo system and a 2.5-MHz GE
Ultrasound probe (GE Medical Systems, Milwaukee, Wis). The mean
gradient and regurgitation scores were assessed with continuous-wave or
color-flow Doppler echocardiography, respectively.Explantation
At 5 months after implantation, the animals were heparinized (3 mg/kg)
and sacrificed by an overdose of pentobarbital (Nembutal; Ovation
Pharmaceuticals Inc, Deerfield, Ill) and KCl intravenously. Native pulmo-
nary valve controls (n ¼ 6) were harvested from nonconflicting
experiments. Each leaflet was examined with X-ray films (Faxitron;
Faxitron Bioptics, Tucson, Ariz) in a horizontal plane perpendicular to
the inflow-outflow axis. Calcium content was spectrophotometrically
quantified for conduit wall and leaflets with a calcium kit (Chema Diagnos-
tica, Monsano, Italy), as already described.10Histology and Immunohistochemistry
Thickness (6-measurement average) and area of pannus were quantified
by planimetry on hematoxylin-eosin–stained sections at thewall and leaflet
portions. The amounts of collagen and organized collagen were assessed by
picrosirius red staining, as already described.13
Cryosections were immunohistochemically stained and quantified for
the following markers in both leaflet and wall portions14: vimentin
(Dako, Glostrup, Denmark), alpha smooth muscle actin (ASMA) (1A4;
Dako), desmin (D33; Serotec, Oxford, UK), smooth muscle myosin heavy
chain (SMMS)–1 (Dako), smoothelin (polyclonal; Santa Cruz Biotech-
nology, Santa Cruz, Calif), endothelial nitric oxide synthetase (3; BD
Pharmingen, Franklin Lakes, NJ), CD45 (1.11.32; Serotec), CD11b
(CC126; Serotec), CD45R (20.96; Serotec), CD8 (BAT82A; VMRD Inc,
Pullman, Wash), and BB-1 (BAS9A; VMRD Inc). Cell nuclei were visual-
izedwith Vectashield 40,6-diamidino-2-phenylindole–containingmounting
medium (Vector Laboratories, Burlingame, Calif).
Pictures were taken using an Axioplan 2 imaging microscope with an
AxiocamMRc5 camera (Zeiss, Oberkochen, Germany) and these objective
lenses: Plan-Neofluar 13/0.025, Plan-Apochromat 13/0.45, 203/0.75,
and 1003/1.4. Axiovision Rel. 4.4. software (Zeiss) was used for image
analysis and morphometry.
For comparison, native ovine aortic and pulmonary valve conduits
were obtained from nonconflicting experiments (n ¼ 5) and asses-
sed for histology, immunohistochemistry, and collagen density and
organization.diovascular Surgery c Volume 147, Number 4 1399
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Cell counts were obtained by assessing maximally 500 cells (total
count) and are expressed as the percentage of positively staining cells on
the total count. Functional endothelialization was quantified by measuring
the inner luminal length and the segments staining positive for endothelial
nitric oxide synthetase and expressed as the fraction of (endothelium
length/inner luminal length) 3 100. Collagen density and organization
are calculated as previously described.15
Data were first compared with a Kruskal-Wallis test. If the
obtained P value was lower than .05, intergroup comparisons were
performed with a Wilcoxon-Mann-Whitney test (SPSS 15.0 for
Windows; SPSS, Inc, Chicago, Ill). P< .05 was considered statistically
significant.RESULTS
Operative Results and Explantation
All 21 valves were successfully implanted and remained
functional for up to 5 months, after which they were
explanted. None of the valves showed signs of infection
or aneurysm formation.Echocardiography
Echocardiographic data are summarized in Table E1. The
diameter of the pulmonary annulus remained unchanged in
all subgroups. Peak velocity across the valves did not
change significantly over time (P > .05). Regurgitation
(score>¼) was never seen at 7 days postoperatively but
became apparent in 1 of 7 cryopreserved aortic homografts
and in 3 of 8 decellularized aortic homografts at 5 months.
None of the coated decellularized grafts showed any
regurgitation at 5 months.Calcification
Calcium content data at 5 month postimplantation are
summarized in Table 1.
Calcium content in the leaflets is low and not different
between the subgroups (P ¼ .732). A calcium content
level of 3 mg/mg dry weight is considered as normal in
bioprosthetic leaflets.13
Cryopreserved homografts showed extremely high cal-
cium contents in the conduit wall (Table 1). Decellulariza-
tion reduced conduit calcification significantly comparedTABLE 1. Calcium content (mg/mg dry weight) in the cryopreserved,
decellularized, and coated decellularized aortic homografts
Variable
Aortic homograft valve
Cryopreserved Decellularized
Decellularized þ
FN/SDF-1a
Conduit
Inflow 28.8  6.6 6.3  3.1* 1.2  0.3*,y
Outflow 157.3  13.3 10.2  4.0* 1.0  0.2*,y
Leaflet 3.8  0.8 3.1  0.6 2.5  1.3
Data are represented as mean  SEM. FN, Fibronectin; SDF, stromal cell–derived
factor. *Significant difference from cryopreserved homografts (P<.05). ySignificant
difference from decellularized homografts (P<.05).
1400 The Journal of Thoracic and Cardiovascular Surwith cryopreservation (P< .05) (Table 1), but could not
eliminate it. Typical examples of Faxitron imaging of aortic
wall end leaflet sections are shown in Figure 1. Localization
of wall calcifications is shown in histologic sections of
cryopreserved and decellularized homografts, but not in
coated grafts (Figure E1).
Coating combined with decellularization eliminated
calcification in the wall portion of the conduits: calcium
content levels were approximately 1 mg/mg dry weight
only (Table 1 and Figures 1 and 2, A).
Endothelialization
In cryopreserved aortic homografts, endothelialization
at 5 months after implantation was 39%  8% and 37%
 5% in the leaflet and the wall, respectively. In decellular-
ized homografts, endothelialization is low: only 10%
to 15% endothelialization was found at explantation
(Figure 2, C). Coating of these significantly improves
endothelialization (P<.05) (Figure 2, C), and the observed
values are comparable to those of cryopreserved
homografts. A typical example of partial endothelialization
of the leaflet of a coated decellularized graft is shown in
Figure E2.
Pannus Formation
Pannus formation (Table E2) is most pronounced in
cryopreserved homografts more specifically in the outflow
side of the conduit. Decellularization of the homograft
significantly reduced pannus formation in this area
(P < .05). After coating and decellularization, pannus
diminished further significantly (P<.05) and remains nearly
undetectable in the outflow tract (Figure 3).
Immune Response
As markers for the immune response, the incidence of
CD45þ, CD45Rþ, CD11bþ, CD8þ, or BB1þ cells was
calculated. BB1þ and CD8þ cells were not detected in
any of the homograft subgroups. The incidence of
CD45þ, CD45Rþ, and CD11bþ cells in the homograft
leaflets and conduit portions is listed in Table 2.
Decellularization alone had no effect on the presence of
CD45þ cells compared with cryopreservation (P> .05).
However, the incidence of CD45Rþ and CD11bþ cells is
systematically lower in the group of decellularized
homografts, although only statistically significant in the
leaflets.
The coating combined with decellularization decreased
the incidence of CD45þ cells further, and this decrease
was statistically significant in the leaflets and in the wall
portion (P<.05) (Table 2 and Figure 2, D).
Extracellular Matrix
Collagen density and organization (Table E3) are studied
in explanted homografts and compared with those of nativegery c April 2014
FIGURE 1. Faxitron images of transversal valve segments after 5 months’ implantation. The cryopreserved homograft (A) illustrates the wall calcification,
a typical complication in these prostheses. The decellularized graft (B) showed limited calcification. The decellularized and coated homograft (C) is devoid
of any calcification.
Flameng et al Evolving Technology/Basic Sciencevalves and of nonimplanted decellularized homografts. In
explanted cryopreserved homografts, collagen organization
is significantly decreased in all layers of the leaflets
(P< .05). Collagen density is also decreased, but mainly
in the ventricularis layer of the leaflets (P < .05). The
decellularization process itself (data on nonimplanted,
decellularized homografts) (Table E3) also reduces
collagen organization in all layers of the leaflets and in
the wall portion (P< .05). It typically decreases collagen
density in the spongiosa of the leaflets and in the wall.
Five-month implantation of decellularized aortic homo-
grafts has little or no effect on the restoration of collagen
organization and density.
Coating of decellularized homografts has a profound
effect on collagen organization and density after implan-
tation. Recovery of collagen organization and density is
complete in practically all layers of the leaflets and in the
wall and is superior to that in decellularized or cryopre-
served homografts (Table E3 and Figure 2, D).E
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The density of interstitial cells (ICs) was determined
in native pulmonary and aortic valve leaflets of non-
implanted cryopreserved and explanted homografts
(Table E4). Cell counting was performed within the
leaflets (ingrowth). In nonimplanted cryopreserved homo-
grafts, the IC density did not differ from that in native
leaflets (P> .05).The Journal of Thoracic and CarAfter implantation, cryopreserved homograft leaflets
seem to have fewer ICs than before, but the difference is
not statistically significant (P>.05).
In decellularized homografts, recellularization within
the leaflets is scarce after 5 months of implantation:
approximately 4% to 5% (P< .05 vs cryopreserved). In
decellularized homografts coated with FN/SDF1a, the
ingrowth of cells in the leaflets tends to be higher than
in noncoated counterparts, but the difference is not
statistically significant (P>.05) (Table E4).Immunohistochemical Analysis of IC Phenotypes
Table E5 contains data on the percentage of cells staining
positive for vimentin, ASMA, SMMS, smoothelin, or
desmin.
In native valves, the difference in IC phenotype between
the leaflets and the wall is a higher ASMAþ cell fraction in
the wall (Table E5).
Cryopreserved valves, and their leaflets as their wall,
show an increase in the fraction of vimentinþ cells, suggest-
ing an increase in fibrocytes after 5 months of implantation.
Decellularized homografts, coated or not, show high
fractions of ASMAþ cells, together with low fractions of
SMMSþ, smoothelinþ, and desminþ cells, in their leaflets.
This suggests the presence of mainly myofibroblasts.
The conduit of uncoated, decellularized homografts
seems characterized by a relatively low fraction of ASMAþ
cells and a high fraction of desminþ cells. This is not thediovascular Surgery c Volume 147, Number 4 1401
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FIGURE 2. The summarized effects of coating of a decellularized homograft on calcification of the homograft wall (A), collagen density in the 3 layers of
the leaflet and in the wall (B), endothelialization on the leaflets and the wall (C), and leukocyte population in the leaflets and the wall (D). The data are
represented as average and SEM. P<.05 versus decellularized grafts (asterisk). FN, Fibronectin; SDF, stromal cell–derived factor.
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a high fraction of ASMAþ cells combined with more
vimentinþ cells.
This suggests that ICs in decellularized conduit walls are
characterized by a smooth muscle cell type, whereas
coating promotes fibroblast and myofibroblast cell types
(Table E5).2
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*DISCUSSION
As could be expected, our results show degeneration of
cryopreserved homografts: the leaflets develop an impaired
collagen organization; inflammation or accumulation of
CD45þ, CD45Rþ, and CD11bþ cells is still present atTABLE 2. Immune response in aortic homografts
Marker Cryopreserved Decellularized Decellularized þ coated
Leaflet
CD45 10.7  1.6 14.3  2.7 2.9  1.3*,y
CD45R 7.6  3.9 0.2  0.1* 0.4  0.2
CD11b 1.2  0.8 0.0  0.0* 0.0  0.0
Conduit
CD45 9.2  2.2 11.5  3.4 1.1  0.4*,y
CD45R 3.8  1.2 1.3  0.4 0.1  0.1
CD11b 1.6  1.3 0.1  0.1 0.0  0.0*,y
Data are represented as mean  SEM. *Significantly different from cryopreserved.
ySignificantly different from decellularized.
1402 The Journal of Thoracic and Cardiovascular Sur5 months. Endothelial coverage and the number of ICs
found in the leaflets are reduced, and there is significant
pannus accumulation. It remains unknown whether the
remaining interstitial cells are still of donor origin or#
0
1
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*
Data represented as mean ± SEM. *, # significant difference from their native or cryopreserved 
counterparts respectively. 
FIGURE 3. Summary of decellularization and/or fibronectin (FN)/
stromal cell–derived factor (SDF)-1a–coating effects on pannus
deposition on the homograft outflow portion. Decellularization
markedly decreases the deposition of pannus, yet FN/SDF-1a coating
further decreases the amount of pannus to levels close to 0. Significant
difference from cryopreserved (asterisk) and decellularized (number
sign), respectively.
gery c April 2014
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phenotype of cryopreserved aortic homograft ICs suggests
an accumulation of fibroblasts after 5 months. These results
confirm studies by others on cryopreserved homografts.16
In patients, in case of the Ross operation, not the homograft
valve but the conduit may become the problem, mainly
because of supravalvular stenosis in smaller than 14-mm
conduit sizes.1
In our study, homograft decellularization partially
reduces wall calcifications and induces a strong tendency
of regurgitation: 3 of 8 grafts have a valvular insufficiency
of more than 2 of 4. In the leaflets, collagen density and
organization are decreased and there is little spontaneous
recellularization: we found 10% to 15% endothelial cell
coverage, and the total IC count in the leaflets was low.
The phenotype of the cells grown in the leaflets shows the
presence of myofibroblasts. Cells repopulating the conduit
walls, however, have another phenotype: they present a
decreased fraction of ASMAþ cells in association with a
significantly increased fraction of desminþ cells, indicative
of differentiation toward smoothmuscle cells. Inflammation
seems to be reduced after decellularization, but there is still a
certain fraction of CD45Rþ and CD11bþ cells detectable.
Pannus formation is significantly less pronounced than in
cryopreserved homografts. Hopkins and colleagues2,3
described that cryopreserved-decellularized pulmonary
homografts retain normal function in sheep, but we could
show that such aortic homografts are more prone to valvular
insufficiency, maybe because of decreases in collagen
density and organization. Other researchers3 recognized
that decellularized allografts have the potential for autolo-
gous recellularization. Yet, none of the valves underwent
significant leaflet recellularization beyond the cusp base,
potentially limiting the long-term performance. We found
a limited degree of recellularization in the leaflets: endothe-
lial coverage was 10% to 15%, and the number of ICs was
approximately 3% to 5% of those of native leaflets.
Based on the observation that decellularized allografts
have a reduced immunogenicity, human implantations in
the right ventricular outflow tract were performed. Cebotari
and colleagues17 found freedom from reoperation of 100%
at 5 years, but 3 of 38 patients had moderate regurgitation
during follow-up. As shown with our previous studies, the
combination of both FN and SDF-1a yields the best result
from the perspective of cell composition and long-term
results when applied to a cross-linked biological prosthesis.
We showed that impregnation with FN/SDF-1a of
pulmonary valve prostheses, constructed from completely
acellular bovine photo-oxidized pericardium, induces
complete recellularization of these valves when implanted
in the RVOT position.7 Although FN and SDF-1a have
had some interchangeable effects on homing of primitive
cells, both have distinct actions and functions as well. The
large FN molecule bears several moieties, of which theThe Journal of Thoracic and Carmost important are related to matrix and cell binding. For
interaction with graft materials, the collagen binding site
is key, yet the cellular binding is mediated mainly by
interaction with a5b1 and a4b1 integrins and by cell
surface glycosylations binding to the heparin-binding
domain.18 Crucial for this application is FN’s ability to
bind and properly present SDF-1a to the cells, thereby
ascertaining proper function.19 Although it has not been
directly linked to calcification, SDF-1a plays an important
role in regulating the immune response by, among others,
preventing leukocyte (mainly T-cell) accumulation,20 of
which calcification related to antigen-mediated immune
response is the result. We believe that the anti-
inflammatory effect of SDF-1a is the primary mechanism
of improved long-term function and not so much the
multipotent cell homing capacity. In our experience,
the coating clearly influenced the immune response
by significantly decreasing the presence of leukocytes
(CD45) combined with a complete absence of calcium
deposits. Such a decreased content of CD45þ cells might
be in accordance with the fugetaxis of immune cells
observed by others.20,21 Another possibility is that SDF-1a
provides an interaction with recipient tissue macrophages to
polarize toward an M2 phenotype. In an (unpublished)
microarray gene expression study, we found an altered
pattern of genes expressed indicative for a transition of the
macrophage phenotype toward an alternatively activated
macrophage. Intriguingly, we have also observed a clear
and positive long-term effect on the matrix. Because there
is no increased recellularization, the most probable mecha-
nism relates to the induction of a different phenotype of
cells able to regulate extracellular matrix turnover. SDF-1a
has a matrix-stabilizing effect by decreasing the expression
of matrix metalloproteinase-9 and tissue inhibitor of
metalloproteinase-1,21 but again, this probably relates
to a shift of the macrophage phenotype from M1 to M2.
A clear association exists between macrophage phenotype
and remodeling outcome in extracellular membrane–based
scaffolds.22
Finally, the results relating to pannus formation and
endothelialization are less obvious to interpret. There is
literature linking SDF-1a to neointimal hyperplasia
in several conditions and experimental setups23 and to
endothelialization by homing of endothelium-related cells
or progenitors.24 However, the actions of SDF-1a are
strongly dependent on cellular reactions and interactions
with the milieu. For example, the presence of other
cytokines induces CD34þ cell proliferation and survival;
on binding to a substrate, such cells increase the available
chemokine (C-X-Cmotif)-4 on their surface.25 In this
interaction between SDF-1a and cellular environment,
NO, as produced by endothelial nitric oxide synthetase of
the present endothelium, has also been shown as an
important mediator.26diovascular Surgery c Volume 147, Number 4 1403
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homing of the appropriate progenitor cells, but it is
more than probable that the milieu provided by the
FN/SDF-1a coating instigates a cellular reaction leading
to faster healing and better controlled tissue deposition
and inflammatory reaction.
Study Limitations
The repopulating cell phenotypes are assessed at the
protein expression level, using immunohistochemistry.
These observations are basically qualitative methods
converted to a numerical score, and they should be
confirmed in a future study by protein biochemical content
assays, assessment of collagen remodeling pathways, and
procollagen to collagen synthesis pathways.
Clinical Relevance of the Study
Although homografts are still the first choice for RVOT
reconstruction, their durability and availability remain
severe drawbacks. Mainly, homografts originating from
aortic root tissue have outflow tract calcifications and
neointimal proliferations. This study suggests that decellu-
larization of homografts, combined with FN/SDF-1a
coating technology, can eliminate these complications.
This should allow, in addition to the use of pulmonary
homografts, use of the aortic homograft for RVOT
reconstruction in congenital heart surgery.
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FIGUREE1. Hematoxylin/eosin-stained sections of cryopreserved (A), decellularized (B), and coated decellularized (C) homografts. The aortic root of the
cryopreserved homograft is heavily calcified, and the leaflet is thickened. There is residual calcification in the sinus area of the decellularized graft and
complete absence of calcium deposition in the coated graft.
FIGURE E2. Partial endothelial layer (endothelial nitric oxide synthe-
tase, green; nuclei, blue) of the leaflet of a coated, decellularized homo-
graft.
TABLE E1. Echocardiographic data 7 days and 5 months after
implantation of aortic homografts
Variable
No. of
observations
Time
7 d 5 mo
Annulus diameter, cm
Cryopreserved 7 2.03  0.08 2.00  0.09
Decellularized 8 1.90  0.04 1.91  0.06
Coated 6 2.13  0.06 2.22  0.08
Peak velocity, m/s
Cryopreserved 7 2.11  0.23 1.55  0.16
Decellularized 8 1.96  0.11 2.00  0.23
Coated 6 1.96  0.32 1.54  0.15
Data are represented as mean  SEM. None of the 5-month data differed from the
corresponding 7-day values (P>.05).
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TABLE E2. Pannus formation on cryopreserved, decellularized, and coated decellularized aortic homografts
Variable Leaflet
Conduit
Inflow Outflow Total wall
Area, mm2
Cryopreserved 0.34  0.14 1.17  0.50 4.68  0.81 2.92  0.67
Decellularized 0.12  0.05 0.18  0.09 1.59  1.06* 0.88  0.54*
Coated and decellularized 0.25  0.10 0.31  0.25 0.13  0.10*,y 0.22  0.13*
Data are given in mm2 and are represented as mean  SEM. *Significant difference from the cryopreserved counterparts. ySignificant difference from the decellularized
counterpart.
TABLE E3. Collagen density and organization in the native, cryopreserved, decellularized, and coated decellularized aortic homografts
Variable
Leaflet
ConduitFibrosa Spongiosa Ventricularis
Collagen density
Native valves 98  1 93  1 99  0 95  1
Unimplanted decellularized homografts 94  3 46  5*,y,z 96  2y 75  1*,z
Explanted homografts
Cryopreserved 84  7 79  12 84  5* 80  4*
Decellularized 88  4* 57  8* 86  3* 75  5*
Decellularized and coated 100  0y,x 98  1*,x 100  0*,y,x 98  0*,y,x
Organized collagen
Native valves 67  4 2  0 28  5 17  3
Unimplanted decellularized homografts 17  7*,z,x 0  0*,z 15  7z,x 0  0*,y,z,x
Explanted homografts
Cryopreserved 18  8* 0  0* 2  1* 16  5
Decellularized 39  6* 2  1 9  3*,y 25  4
Decellularized and coated 75  5y,x 5  2y 31  7y,x 28  4
Data are represented as mean  SEM. *Significant difference from the native counterparts. ySignificant difference from the cryopreserved counterparts. zSignificant difference
from the decellularized counterparts. xSignificant difference from the coated cellularized counterparts.
TABLE E4. Cell count of aortic valve leaflets
Variable Cell count (ingrowth)
Native valves 7932  1386
Unimplanted homografts
Cryopreserved 8347  1716
Explanted homografts
Cryopreserved 5329  1265
Decellularized 334  146*,y
Decellularized and coated 1007  455*,y
Data are represented as mean  SEM. *Significant difference from the native
counterparts. ySignificant difference from the implanted cryopreserved counterparts.
TABLE E5. Immunohistochemistry
Variable Native Cryopreserved Decellularized Decellularized and FN/SDF1a
Leaflet
Vimentin 33.4  1.7 52.4  9.6* 39.8  7.6y 34.8  6.9z
ASMA 14.4  0.8 12.3  4.1 27.5  7.5 34.4  8.9*
SMMS 3.7  0.7 0.3  0.2* 0.3  0.1* 1.1  0.8*
Smoothelin 2.0  0.4 0.6  0.3* 0.7  0.3* 0.1  0.1*
Desmin 1.2  0.2 0.7  0.4 0  0*,y 0.9  0.5z
Wall
Vimentin 32.5  1.5 81.0  2.2* 35.5  5.6y 61.5  7.9*,z
ASMA 34.8  5.2 41.6  7.1 19.7  2.2*,y 32.2  10.5
SMMS 6.3  0.8 5.2  1.5 1.5  1.5* 0.9  0.9*,y
Smoothelin 5.1  0.6 2.5  0.8* 0.2  0.1*,y 0  0*,y
Desmin 2.8  0.5 4.8  2.4 11.1  2.1*,y 5.6  3.6
Data are representedasmeanSEM.FN, Fibronectin;SDF, stromal cell–derived factor;ASMA, alpha smoothmuscle actin;SMMS, smoothmusclemyosin heavychain. *Significant
difference from the native counterparts. ySignificant difference from the cryopreserved counterparts. zSignificant difference from the decellularized counterparts.
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